Pb-BCY-20603

N/A

Report date: 2025/10/31 15:08:11

Base Information

Drug NamePb-BCY-20603
Drug Alias NamePb BCY20603Pb-BCY20603Pb-BCY-20603
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Radiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radioactive therapeutic agent +[4
Mechanisms of ActionIonising radiation emittersMatrix metalloproteinase 14 binders
TargetsMatrix metalloproteinase 14
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A